Related Experiment Video
Updated: Jul 3, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis
Jianyun Xie1, Linjie Lu1, Jiali Zhang1
1Department of Urology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Objective:
Circular ribose nucleic acids (circRNAs) are implicated in tumor progression and drug resistance of prostate cancer (PCa). The current work explored the function of circ_0005203 (circTHSD4) in the malignancy and docetaxel (DTX) resistance of PCa.
Methods:
circTHSD4 expression within PCa as well as matched non-carcinoma samples was measured through real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). In addition, a subcellular fraction assay was conducted to determine circTHSD4 subcellular localization within PCa cells. In addition, we performed a Western blot (WB) assay to detect high-mobility-group A2 protein (HMGA2) levels. Besides, functional associations of two molecules were investigated through dual luciferase reporter assay. Cell Counting Kit (CCK)-8, colony formation together with Transwell assay was conducted to assess malignant phenotypes of PCa cells, whereas flow cytometry was performed to determine cell apoptosis. Furthermore, a xenograft mouse model was constructed to verify the effect of circTHSD4 on the carcinogenesis of PCa cells.
Results:
According to RT-qPCR results, circTHSD4 was up-regulated within PCa tissues and cells, which predicted the dismal prognostic outcome of PCa cases. circTHSD4 silencing within PCa cells markedly suppressed cell growth, migration, and colony formation. circTHSD4 silencing remarkably elevated PCa cell apoptosis and carcinogenesis within the xenograft model. Further, circTHSD4 silencing enhanced docetaxel (DTX) sensitivity in PCa cells. Furthermore, we demonstrated that circTHSD4 modulated the malignancy of PCa cells by regulating HMGA2 expression through sponging miR-203.
Conclusion:
Together, our findings suggest that circTHSD4 overexpression could promote the malignant phenotype and DTX resistance in PCa through the regulation of the miR-203/HMGA2 axis.
Insights
Circular RNA circTHSD4 promotes prostate cancer progression and docetaxel resistance by regulating the miR-203/HMGA2 pathway. Silencing circTHSD4 inhibits tumor growth and enhances drug sensitivity in prostate cancer models.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) play a role in prostate cancer (PCa) progression and drug resistance.
- circ_0005203 (circTHSD4) is a circRNA implicated in PCa malignancy and docetaxel (DTX) resistance.
Purpose of the Study:
- To investigate the function of circTHSD4 in prostate cancer (PCa) malignancy and docetaxel (DTX) resistance.
- To elucidate the underlying molecular mechanisms involving circTHSD4, miR-203, and HMGA2 in PCa.
Main Methods:
- circTHSD4 expression was quantified using RT-qPCR in PCa tissues and cells.
- Cellular assays (CCK-8, colony formation, Transwell, flow cytometry) and a xenograft mouse model were used to assess PCa cell malignancy and apoptosis.
- Western blot and dual-luciferase reporter assays were employed to investigate the interaction between circTHSD4, miR-203, and HMGA2.
Main Results:
- circTHSD4 was significantly upregulated in PCa tissues and cells, correlating with poor prognosis.
- Silencing circTHSD4 suppressed PCa cell growth, migration, and colony formation, while increasing apoptosis.
- circTHSD4 silencing enhanced docetaxel sensitivity and inhibited PCa carcinogenesis in vivo.
- circTHSD4 was found to regulate HMGA2 expression by sponging miR-203.
Conclusions:
- Overexpression of circTHSD4 promotes malignant phenotypes and docetaxel resistance in prostate cancer.
- The circTHSD4/miR-203/HMGA2 axis is a key regulator of PCa progression and drug resistance.
- circTHSD4 represents a potential therapeutic target for overcoming docetaxel resistance in prostate cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Drugs that Stabilize Microtubules
MicroRNAs
Drugs that Destabilize Microtubules
The Tumor Microenvironment

